.gif "LifePoint Health logo")
LifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery. The company's hospitals also offer outpatient services comprising same-day surgery, laboratory, X-ray, respiratory therapy, imaging, sports medicine, and lithotripsy. In addition, it owns and operates schools of nursing and other allied health professions. As of December 31, 2017, the company operated 71 hospital campuses with a total of 9,254 licensed beds in 22 states. The company was formerly known as LifePoint Hospitals, Inc. and changed its name to LifePoint Health, Inc. in May 2015. LifePoint Health, Inc. was founded in 1997 and is based in Brentwood, Tennessee.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry General medical & surgical hospitals
Sub-IndustryHealth Care Facilities
SectorMedical
SymbolNASDAQ:LPNT
CUSIP53219L10
Phone615-920-7000
Debt
Debt-to-Equity Ratio1.27
Current Ratio1.85
Quick Ratio1.63
Price-To-Earnings
Trailing P/E Ratio17.77
Forward P/E Ratio14.05
P/E Growth1.34
Sales & Book Value
Annual Sales$7.26 billion
Price / Sales0.34
Cash Flow$12.6471 per share
Price / Cash5.10
Book Value$57.99 per share
Price / Book1.11
Profitability
EPS (Most Recent Fiscal Year)$3.63
Net Income$102.40 million
Net Margins0.65%
Return on Equity7.04%
Return on Assets2.56%
Miscellaneous
Employees42,000
Outstanding Shares38,730,000
Market Cap$2.50 billion
LifePoint Health (NASDAQ:LPNT) Frequently Asked Questions
What is LifePoint Health's stock symbol?
LifePoint Health trades on the NASDAQ under the ticker symbol "LPNT."
How will LifePoint Health's stock buyback program work?
LifePoint Health declared that its Board of Directors has initiated a stock repurchase plan on Friday, October 27th 2017, which permits the company to buyback $200,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Shares buyback plans are typically a sign that the company's board believes its stock is undervalued.
How were LifePoint Health's earnings last quarter?
LifePoint Health Inc (NASDAQ:LPNT) announced its earnings results on Friday, July, 27th. The company reported $1.27 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.08 by $0.19. The company earned $1.57 billion during the quarter, compared to the consensus estimate of $1.58 billion. LifePoint Health had a net margin of 0.65% and a return on equity of 7.04%. The business's quarterly revenue was down 1.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.96 earnings per share. View LifePoint Health's Earnings History.
When is LifePoint Health's next earnings date?
What guidance has LifePoint Health issued on next quarter's earnings?
LifePoint Health updated its FY18 earnings guidance on Friday, July, 27th. The company provided EPS guidance of $4.50-4.93 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.28. The company issued revenue guidance of $6.25-6.32 billion, compared to the consensus revenue estimate of $6.35 billion.
What price target have analysts set for LPNT?
17 equities research analysts have issued twelve-month price objectives for LifePoint Health's shares. Their predictions range from $45.00 to $74.00. On average, they anticipate LifePoint Health's share price to reach $59.00 in the next twelve months. This suggests that the stock has a possible downside of 8.5%. View Analyst Price Targets for LifePoint Health.
What is the consensus analysts' recommendation for LifePoint Health?
17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LifePoint Health in the last year. There are currently 1 sell rating, 14 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for LifePoint Health.
What are Wall Street analysts saying about LifePoint Health stock?
Here are some recent quotes from research analysts about LifePoint Health stock:
- 1. According to Zacks Investment Research, "LifePoint Health’s stock has, however, underperformed its industry, year to date. The company is faced with a challenging volume environment and weakness in revenue growth. Increasing expenses, which have outpaced revenue growth thereby squeezing operating margins, is another concern.. Hoewever, its acquisition pipeline remains strong and it sees several opportunities, including hospitals, health systems, and end-market transactions to expand its key services, which should drive its long term growth." (7/24/2018)
- 2. Cantor Fitzgerald analysts commented, "LPNT reported in-line 4Q17 results, with revenue that is short of the FactSet consensus but adjusted EBITDA that was in-line. The company has, however, increased its provision for bad debt, and includes the new, more accurate estimate as an adjustment." (2/23/2018)
Are investors shorting LifePoint Health?
LifePoint Health saw a decrease in short interest in July. As of July 31st, there was short interest totalling 2,324,213 shares, a decrease of 55.2% from the July 13th total of 5,182,362 shares. Based on an average trading volume of 2,121,503 shares, the days-to-cover ratio is presently 1.1 days. Currently, 6.2% of the shares of the stock are short sold. View LifePoint Health's Current Options Chain.
Who are some of LifePoint Health's key competitors?
Who are LifePoint Health's key executives?
LifePoint Health's management team includes the folowing people:
- Mr. William F. Carpenter III, Chairman & CEO (Age 63)
- Mr. David M. Dill, Pres & COO (Age 49)
- Mr. Michael S. Coggin, Exec. VP & CFO (Age 48)
- Mr. John P. Bumpus, Exec. VP & Chief Admin. Officer (Age 57)
- John Michael Grooms, VP and Chief Accounting Officer (Age 40)
Has LifePoint Health been receiving favorable news coverage?
News headlines about LPNT stock have been trending positive this week, according to Accern Sentiment Analysis. Accern ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. LifePoint Health earned a news impact score of 0.28 on Accern's scale. They also gave news headlines about the company an impact score of 47.47 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near term. View Recent Headlines for LifePoint Health.
Who are LifePoint Health's major shareholders?
LifePoint Health's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.55%), American Century Companies Inc. (10.91%), Dimensional Fund Advisors LP (8.46%), LSV Asset Management (5.74%), Diamond Hill Capital Management Inc. (3.93%) and Letko Brosseau & Associates Inc. (3.85%). Company insiders that own LifePoint Health stock include David M Dill, John P Bumpus, Marguerite Kondracke, Richard H Evans and William F Carpenter III. View Institutional Ownership Trends for LifePoint Health.
Which institutional investors are selling LifePoint Health stock?
LPNT stock was sold by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC, American Century Companies Inc., Millennium Management LLC, Diamond Hill Capital Management Inc., Retirement Systems of Alabama, State of New Jersey Common Pension Fund D, First Trust Advisors LP and Point72 Asset Management L.P.. Company insiders that have sold LifePoint Health company stock in the last year include David M Dill and Marguerite Kondracke. View Insider Buying and Selling for LifePoint Health.
Which institutional investors are buying LifePoint Health stock?
LPNT stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., SG Americas Securities LLC, Schwab Charles Investment Management Inc., Profit Investment Management LLC, Alambic Investment Management L.P., Bank of New York Mellon Corp, James Investment Research Inc. and Boston Partners. View Insider Buying and Selling for LifePoint Health.
How do I buy shares of LifePoint Health?
Shares of LPNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is LifePoint Health's stock price today?
One share of LPNT stock can currently be purchased for approximately $64.50.
How big of a company is LifePoint Health?
LifePoint Health has a market capitalization of $2.50 billion and generates $7.26 billion in revenue each year. The company earns $102.40 million in net income (profit) each year or $3.63 on an earnings per share basis. LifePoint Health employs 42,000 workers across the globe.
How can I contact LifePoint Health?
LifePoint Health's mailing address is 330 Seven Springs Way, Brentwood TN, 37027. The company can be reached via phone at 615-920-7000 or via email at [email protected]
MarketBeat Community Rating for LifePoint Health (NASDAQ LPNT)
MarketBeat's community ratings are surveys of what our community members think about LifePoint Health and other stocks. Vote "Outperform" if you believe LPNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LPNT will underperform the S&P 500 over the long term. You may vote once every thirty days.
